TritonPoint Partners’s Amgen AMGN Stock Holding History

TritonPoint Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$483K	Buy	1,334 +576	+76%	+$197K	0.04%	231
2026 Q1	$267K	Buy	+758	New	+$270K	0.1%	171

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

TritonPoint Partners's AMGN Position: Q2 2026 in Review

TritonPoint Partners increased its Amgen (AMGN) stake by 76% in Q2 2026, buying an estimated $197K and bringing the position to 1,334 shares worth $483K. The position accounts for 0.04% of the portfolio, ranked #231.

TritonPoint Partners first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

TritonPoint Partners held 1,334 shares of Amgen worth $483K as of Q2 2026.
TritonPoint Partners bought 576 Amgen shares in Q2 2026, an estimated $197K.
Amgen made up 0.04% of TritonPoint Partners's portfolio in Q2 2026, its #231 holding.
TritonPoint Partners first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on TritonPoint Partners's 13F filing for Q2 2026, filed 13 Aug 2026.